Cargando…

Prognosis of patients with hepatocellular carcinoma and hypersplenism after surgery: a single-center experience from the People’s Republic of China

PURPOSE: As prognosis of patients with hepatocellular carcinoma (HCC) and hypersplenism is rarely reported, this study examined prognostic factors for patients who underwent surgery for this condition. PATIENTS AND METHODS: This study retrospectively analyzed prognostic factors in 181 consecutive HC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Cong, Zhao, Hong, Zhao, Jianjun, Li, Zhiyu, Huang, Zhen, Zhang, Yefan, Bi, Xinyu, Cai, Jianqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061180/ https://www.ncbi.nlm.nih.gov/pubmed/24959082 http://dx.doi.org/10.2147/OTT.S64921

Ejemplares similares

A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma
por: Li, Xingchen, et al.
Publicado: (2021)

Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review
por: Wei, Zhewen, et al.
Publicado: (2022)

Should surgery be conducted for small nonfunctioning pancreatic neuroendocrine tumors: a systematic review
por: Guo, Jingfei, et al.
Publicado: (2017)

Prognostic significance of the preoperative alkaline phosphatase‑to‑albumin ratio in patients with hepatocellular carcinoma after hepatic resection
por: Wang, Yikai, et al.
Publicado: (2023)

Simultaneous hepatic resection benefits patients with synchronous colorectal cancer liver metastases
por: Li, Yuan, et al.
Publicado: (2016)

Variants Identified by Hepatocellular Carcinoma and Chronic Hepatitis B Virus Infection Susceptibility GWAS Associated with Survival in HBV-Related Hepatocellular Carcinoma
por: Li, Cong, et al.
Publicado: (2014)

What is the optimal number of neoadjuvant chemotherapy cycles for resectable colorectal liver oligometastases?
por: Chen, Qichen, et al.
Publicado: (2021)

Preoperative D-dimer and Gamma-Glutamyltranspeptidase Predict Major Complications and Survival in Colorectal Liver Metastases Patients After Resection()
por: Chen, Qichen, et al.
Publicado: (2019)

From the completion of neoadjuvant chemotherapy to surgery for colorectal cancer liver metastasis: What is the optimal timing?
por: Chen, Qichen, et al.
Publicado: (2020)

Upgraded nomograms for the prediction of complications and survival in patients with colorectal liver metastases treated with neoadjuvant chemotherapy followed by hepatic resection
por: Chen, Qichen, et al.
Publicado: (2021)

Preoperatively elevated RDW-SD and RDW-CV predict favorable survival in intrahepatic cholangiocarcinoma patients after curative resection
por: Li, Xingchen, et al.
Publicado: (2021)

Successful Splenectomy for Hypersplenism in Wilson’s Disease: A Single Center Experience from China
por: Li, Liang-Yong, et al.
Publicado: (2015)

The prognostic factors of primary colorectal sarcoma and the clinical outcomes of negative lymph node dissection
por: Wei, Zhewen, et al.
Publicado: (2021)

Development of a Metastasis-Related Immune Prognostic Model of Metastatic Colorectal Cancer and Its Usefulness to Immunotherapy
por: Luo, Zhiwen, et al.
Publicado: (2021)

An elevated preoperative cholesterol-to-lymphocyte ratio predicts unfavourable outcomes in colorectal cancer liver metastasis patients receiving simultaneous resections: a retrospective study
por: Deng, Yiqiao, et al.
Publicado: (2023)

ARID2: A new tumor suppressor gene in hepatocellular carcinoma
por: Zhao, Hong, et al.
Publicado: (2011)

Clinical Analysis of 15 Cases of Gallbladder Neuroendocrine Carcinoma and Comparison with Gallbladder Adenocarcinoma Using a Propensity Score Matching
por: Yan, Shida, et al.
Publicado: (2020)

The combination of preoperative D-dimer and CA19-9 predicts lymph node metastasis and survival in intrahepatic cholangiocarcinoma patients after curative resection
por: Chen, Qichen, et al.
Publicado: (2020)

Impact of Postoperative Infectious Complications on Long-Term Outcomes for Patients Undergoing Simultaneous Resection for Colorectal Cancer Liver Metastases: A Propensity Score Matching Analysis
por: Chen, Qichen, et al.
Publicado: (2022)

CEA Level, Radical Surgery, CD56 and CgA Expression Are Prognostic Factors for Patients With Locoregional Gastrin-Independent GNET
por: Li, Yuan, et al.
Publicado: (2016)

Differences of intraoperative outcomes and postoperative complications between intrahepatic cholangiocarcinoma and colorectal liver metastasis in different surgical methods
por: Chen, Qichen, et al.
Publicado: (2021)

Hypersplenism: History and current status
por: Lv, Yunfu, et al.
Publicado: (2016)

Does splenectomy significantly improve the prognosis of hepatocellular carcinoma patients with hypersplenism? A systematic review and meta-analysis
por: Shi, Xue-Bing, et al.
Publicado: (2021)

Effect of partial splenic embolization on transarterial chemoembolization for hepatocellular carcinoma with hypersplenism
por: Liu, Jibing, et al.
Publicado: (2021)

Splenectomy may facilitate systemic therapy for advanced hepatocellular carcinoma with hypersplenism
por: Zhang, Er-Lei, et al.
Publicado: (2023)

Hypersplenic Anæmia relieved by Splenectomy
por: Nelson, M. G.
Publicado: (1950)

Systematic review of resecting primary tumor in MNETs patients with unresectable liver metastases
por: Guo, Jingfei, et al.
Publicado: (2016)

Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia
por: Chen, Yaocheng, et al.
Publicado: (2020)

Recent advances in the ARID family: focusing on roles in human cancer
por: Lin, Chen, et al.
Publicado: (2014)

Splenectomy before hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A retrospective study
por: Zhou, Chenyang, et al.
Publicado: (2021)

Splenic artery embolization with detachable balloons for hypersplenism
por: Pang, Xiaoxi, et al.
Publicado: (2018)

Does the Warren Shunt Correct Hypersplenism?
por: Lodge, J. Peter A., et al.
Publicado: (1990)

Radiotherapy for hypersplenism from congestive splenomegaly
por: Liu, Mu-Tai, et al.
Publicado: (2004)

Nomogram for tumour response based on prospective cohorts of hepatocellular carcinoma patients receiving immunotherapy combined with targeted therapy: development and validation
por: Chen, Qichen, et al.
Publicado: (2023)

Safety of Simultaneous Hepatectomy and Splenectomy in the Treatment of Hepatocellular Carcinoma Complicated with Hypersplenism: A Meta-analysis
por: Liu, Xuefeng, et al.
Publicado: (2019)

Simultaneous hepatectomy and splenectomy versus hepatectomy alone for hepatocellular carcinoma complicated by hypersplenism: a meta-analysis
por: Li, Wei, et al.
Publicado: (2015)

Splenomegaly and hypersplenism in hepatic vena cava syndrome
por: Man Shrestha, Santosh
Publicado: (2021)

Antibody and complement levels in patients with hypersplenism associated with cirrhotic portal hypertension and therapeutic principles
por: Zhang, Kun, et al.
Publicado: (2022)

Effects of hypersplenism on the outcome of hepatectomy in hepatocellular carcinoma with hepatitis B virus related portal hypertension
por: Chen, Xiao, et al.
Publicado: (2023)

Population and health policy in the People's Republic of China /
por: Zhen, Bizhao
Publicado: (1976)

Cannot write session to /tmp/vufind_sessions/sess_aocfpcnbvbbktai8qj4rfddf3v